C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a ...
WATERTOWN, Mass., April 08, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, presented a poster today at
Source: eagletribune.com